These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 1712706

  • 1. Drug treatment in precocious puberty.
    Wheeler MD, Styne DM.
    Drugs; 1991 May; 41(5):717-28. PubMed ID: 1712706
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis and management of precocious puberty.
    Wheeler MD, Styne DM.
    Pediatr Clin North Am; 1990 Dec; 37(6):1255-71. PubMed ID: 2147987
    [Abstract] [Full Text] [Related]

  • 3. Update on therapy for precocious puberty.
    Wheeler MD.
    Compr Ther; 1994 Dec; 20(6):351-5. PubMed ID: 8062545
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG.
    Horm Res; 1994 Dec; 41 Suppl 2():14-5. PubMed ID: 8088698
    [Abstract] [Full Text] [Related]

  • 5. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 6. Central precocious puberty: current treatment options.
    Antoniazzi F, Zamboni G.
    Paediatr Drugs; 2004 Oct; 6(4):211-31. PubMed ID: 15339200
    [Abstract] [Full Text] [Related]

  • 7. The treatment of precocious puberty.
    Wheeler MD, Styne DM.
    Endocrinol Metab Clin North Am; 1991 Mar; 20(1):183-90. PubMed ID: 1827623
    [Abstract] [Full Text] [Related]

  • 8. Precocious puberty and statural growth.
    Carel JC, Lahlou N, Roger M, Chaussain JL.
    Hum Reprod Update; 2004 Mar; 10(2):135-47. PubMed ID: 15073143
    [Abstract] [Full Text] [Related]

  • 9. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 10. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty.
    Lee PA, Houk CP.
    Treat Endocrinol; 2006 Sep; 5(5):287-96. PubMed ID: 17002488
    [Abstract] [Full Text] [Related]

  • 12. Growth in precocious puberty.
    Brown JJ, Warne GL.
    Indian J Pediatr; 2006 Jan; 73(1):81-8. PubMed ID: 16444068
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and management of precocious sexual maturation: an updated review.
    Cheuiche AV, da Silveira LG, de Paula LCP, Lucena IRS, Silveiro SP.
    Eur J Pediatr; 2021 Oct; 180(10):3073-3087. PubMed ID: 33745030
    [Abstract] [Full Text] [Related]

  • 14. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty.
    Breyer P, Haider A, Pescovitz OH.
    Clin Obstet Gynecol; 1993 Sep; 36(3):764-72. PubMed ID: 8403623
    [Abstract] [Full Text] [Related]

  • 16. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 17. [Central precocious puberty].
    Krysiak R, Marek B, Okopień B.
    Endokrynol Pol; 2008 Jul; 59(6):530-40. PubMed ID: 19347819
    [Abstract] [Full Text] [Related]

  • 18. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Jul; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 19. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A, Rivarola MA.
    Horm Res; 1998 Jul; 49(5):226-32. PubMed ID: 9568807
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.